ArticleEMBO reports2016

Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness.

Vijayalakshmi Kari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.